Investigational Site Number : 3920001

Okayama 701-1192

1 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab — Enrolling by invitation